Thymoquinone effects on DMH-induced erythrocyte oxidative stress and haematological alterations during colon cancer promotion in rats

Journal of Functional Foods

Volumn 5, Issue 3, 2013, Pages 1310-1316

  Jrah Harzallah, Hanene ^a   Ben Hadj Khalifa, Sonia ^a,b   Maloul, Aya ^a   El Ghali, Rabeb ^a   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

1,2 Dimethylhydrazine; Erythrocyte; Haematological parameters; Oxidative stress; Thymoquinone

Indexed keywords

NIGELLA SATIVA; RATTUS;

EID: 84880510443     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.04.017     Document Type: Article

References (51)

1. Arafa el-S.A., Zhu Z.I., Shah Q., Wani G., Barakat B.M., Racoma I., El-Mahdy M.A., Wani A. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutation Research 2011, 706:28-35.
2. Arbos K.A., Claro L.M., Borges L., Santos C.A., Weffort-Santos A.M. Human erythrocytes as a system for evaluating the antioxidant capacity of vegetable extracts. Nutrition Research 2008, 28:457-463.
3. Badary O.A., Taha R.A., Gamal el-Din A.M., Abdel-Wahab M.H. Thymoquinone is a potent superoxide anion scavenger. Drug Chemical Toxicology 2003, 26:87-98.
4. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Analytical Biochemistry 1971, 44:276-287.
5. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., Monks T.J. Role of quinones in toxicology. Chemical Research in Toxicology 2000, 13:135-160.
6. Childress M.O. Hematologic abnormalities in the small animal cancer patient. Veterinary Clinics of North America: Small Animal Practice 2012, 42:123-155.
7. Çimen M.Y. Free radical metabolism in human erythrocytes. Clinica Chimica Acta 2008, 390:1-11.
8. Clairbone A. Catalase activity. Handbook of methods for oxygen radical research 1985, 283-284. CRC Press, Boca Raton, FL. R.A. Greenwald (Ed.).
9. Clemens M.R., Waller H.D. Lipid peroxidation in erythrocytes. Chemistry and Physics of Lipids 1987, 45:251-268.
10. Devasena T., Menon V.P., Rajasekharan K.N. Prevention of 1,2-dimethylhydrazineinduced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis. Pharmacological Reports 2006, 58:229-235.
11. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989, 6:67-75.
12. Facundo H.T., Brandt C.T., Owen J.S., Lima V.L. Elevated levels of erythrocyte conjugated dienes indicate increased lipid peroxidation in schistosomiasis mansoni patients. Brazilian Journal of Medical and Biological Research 2004, 37:957-962.
13. Fiala E.S. Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine and azoxymethane. Cancer 1977, 40:2436-2445.
14. Flohé L., Günzler W.A.I. Assays of glutathione peroxidise. Methods in Enzymology 1984, 105:114-121.
15. Föller M., Huber S.M., Lang F. Erythrocyte programmed cell death. IUBMB Life 2008, 60:661-668.
16. Gali-Muhtasib H.U., Abou Kheir W.G., Kheir L.A., Darwiche N., Crooks P.A. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anti-cancer Drugs 2004, 15:389-399.
17. Gali-Muhtasib H., Diab-Assaf M., Boltze C., Al-Hmaira J., Hartig R., Roessner A., Schneider-Stock R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. International Journal of Oncology 2004, 25:857-866.
18. Gali-Muhtasib H., Ocker M., Kuester D., Krueger S., El-Hajj Z., Diestel A., Evert M., El-Najjar N., Peters B., Jurjus A., Roessner A., Schneider-Stock R. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. Journal of Cellular and Molecular Medicine 2008, 12:330-342.
19. Ghadi E.F., Ghara A.R., Bhattacharyya S., Dhawan D.K. Selenium as a chemopreventive agent in experimentally induced colon carcinogenesis. World Journal of Gastrointestinal Oncology 2009, 1:74-81.
20. Gomollón F., Gisbert I.P. Anemia and inflammatory bowel diseases. World Journal of Gastroenterology 2009, 15:4659-4665.
21. Huang Y.L., Sheu J.Y., Lin T.H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clinical Biochemistry 1999, 32:131-136.
22. Blair Ian A. DNA adducts with lipid peroxidation products. Journal of Biological Chemistry 2008, 238:15545-15549.
23. Kempe D.S., Akel A., Lang P.A., Hermle T., Biswas R., Muresanu J., Friedrich B., Dreischer P., Wolz C., Schumacher U., Peschel A., Götz F., Döring G., Wieder T., Gulbins E., Lang F. Suicidal erythrocyte death in sepsis. Journal of Molecular Medicine 2007, 85:273-281.
24. Khader M., Bresgen N., Eckl P.M. In vitro toxicological properties of thymoquinone. Food and Chemical Toxicology 2009, 47:129-133.
25. Kuki W., Takahashi Y., Yonei H., Maeda M., Ota T., Odashima S., Yamane T., Koshimizu K., Ohigashi H. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Research 1998, 56:2550-2556.
26. Kurata M., Suzuki M., Agar N.S. Antioxidant systems and erythrocyte lifespan in mammals. Comparative Biochemistry and Physiology Part B 1993, 106:477-487.
27. Laoui D., Van Overmeire E., Movahedi K., Van den Bossche J., Schouppe E., Mommer C., Nikolaou A., Morias Y., De Baetselier P., Van Ginderachter J.A. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology 2011, 216:192-202.
28. Messarah M., Saoudi M., Boumendjel A., Boulakoud M.S., Feki A.E. Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environmental Toxicology and Pharmacology 2011, 31:33-41.
29. Nazifi S., Razavi S.M., Mansourian M., Nikahval B., Moghaddam M. Studies on correlation among parasitemia and some haemolytic indices in two tropical diseases (theileriosis and anaplasmosis) in Fars province of Iran. Tropical Animal Health and Production 2008, 40:47-53.
30. Pandey K.B., Rizvi S.I. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxidative Medicine and Cellular Longevity 2010, 3:2-12.
31. Pandey K.B., Rizvi S.I. Biomarkers of oxidative stress in red blood cells. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic 2011, 155:131-136.
32. Papas A.M. Determinants of antioxidant status in humans. Lipid 1996, 31:77-82.
33. Razavi S.M., Nazifi S., Bateni M., Rakhshandehroo E. Alterations of erythrocyte antioxidant mechanisms: antioxidant enzymes, lipid peroxidation and serum trace elements associated with anemia in bovine tropical theileriosis. Veterinary Parasitology 2011, 180:209-214.
34. Sankaranarayanan C., Pari L. Thymoquinone ameliorates chemical induced oxidative stress and B-cell damage in experimental hyperglycemic rats. Chemico-Biological Interactions 2011, 190:148-154.
35. Sayed-Ahmed M.M., Aleisa A.M., Al-Rejaie S.S., Al-Yahya A.A., Al-Shabanah O.A., Hafez M.M., Nagi M.N. Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signalling. Oxidative Medicine and Cellular Longevity 2010, 3:254-261.
36. Seven A., Civelek S., Inci E., Inci F., Korkut N., Burçak G. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clinical Biochemistry 1999, 32:369-373.
37. Shafeeque A., Zafarul H.B. Alleviation of plasma, erythrocyte and liver lipidemic-oxidative stress by thymoquinone and limonene in atherogenic suspension fed rats. Journal of Functional Foods 2012, 10.1016/j.jff.2012.10.014.
38. Shiono H., Yagi Y., Chikayama Y., Miyazaki S., Nakamura I. Oxidative damage and phosphatidylserine expression of red blood cells in cattle experimentally infected with Theileria sergenti. Parasitology Research 2003, 89:228-234.
39. Siems W.G., Sommerburg O., Grune T. Erythrocyte free radical and energy metabolism. Clinical Nephrology 2000, 53:S9-S17.
40. Staniek K., Gille L. Is thymoquinone an antioxidant. BMC Pharmacology 2010, 10:1-9.
41. Tsantes A.E., Bonovas S., Travlou A., Sitaras N.M. Redox imbalance, macrocytosis, and RBC homeostasis. Antioxidants and Redox Signaling 2006, 8:1205-1216.
42. Tyurina Y.Y., Shvedova A.A., Kanai K., Tyurin V.A., Kommineni C., Quinn P.J., Schor N.F., Fabisiak J.P., Kagan V.E. Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology 2000, 148:93-101.
43. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology 2007, 39:44-84.
44. Valko M., Rhodes C.I., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006, 160:1-40.
45. Vaupel P. The role of hypoxia-induced factors in tumor progression. The Oncologist 2004, 9:10-17.
46. Vieira-de-Abreu A., Campbell R.A., Weyrich A.S., Zimmerman G.A. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Seminars in Immunopathology 2012, 34:5-30.
47. Weiss S.J., Lo Buglio A.F. Biology of diseased phagocyte generated oxygen metabolites and cellular injury. Laboratory Investigation 1982, 47:5-18.
48. Woo C.C., Kumar K.P., Sethi G., Tan K.H. Thymoquinone: potential cure for inflammatory disorder and cancer. Biochemical Pharmacology 2011, 183:443-451.
49. Worthen D., Ghosheh O., Crooks P. The in vitro antitumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Research 1998, 18:1527-1532.
50. Wright R.O., Lewander W.J., Woolf A.D. Methemoglobinemia: etiology, pharmacology and clinical management. Annals of Emergency Medicine 1999, 34:646-656.
51. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 1976, 15:212-216.